为什么普通医疗记录无法用于结算Why Ordinary Medical Records Can't Be Used for Settlement

传统医疗记录的逻辑是描述性的:记录发生了什么(诊断、处方、检查结果)。支付方据此核实服务是否发生,然后付款。Traditional medical records are descriptive: they document what happened (diagnoses, prescriptions, test results). Payers verify these records and pay accordingly.

预防干预的挑战在于:核心"服务结果"是没有发生疾病。支付方面对的问题不是"干预是否发生了",而是"干预是否真的防止了疾病"——这是一个因果推断问题,不是记录核查问题。The challenge with preventive interventions is that the core "service outcome" is disease not occurring. The payer's question isn't "did the intervention happen?" but "did it actually prevent disease?" — a causal inference problem, not a record verification problem.

关键区别:Key Distinction:普通健康记录可以证明"参与者的血压在项目结束后下降了"。可结算证据需要证明"血压下降是因为干预,而不是因为参与者本来就是更注重健康的人"。这需要因果推断,不是描述性统计。Ordinary health records can prove "participants' blood pressure decreased after the program." Billable evidence must prove "the decrease was caused by the intervention, not because healthier people self-selected into the program." This requires causal inference, not descriptive statistics.

可结算证据的六个核心构成要素Six Core Elements of Billable Evidence

要素 01Element 01

干预描述Intervention Description

干预类型(药物/生活方式/数字健康)、干预时长、参与人群基本特征、数据来源说明。Intervention type (medication/lifestyle/digital health), duration, population characteristics, data source description.

必需项Required
要素 02Element 02

基线特征对比Baseline Characteristics Comparison

匹配前干预组与对照组的基线差异,标准化均值差(SMD),证明两组可比性。Pre-matching baseline differences between treatment and control groups, SMD, proving group comparability.

必需项Required
要素 03Element 03

PSM匹配质量说明PSM Matching Quality

倾向评分模型说明、匹配方法(最近邻/核匹配等)、匹配后SMD改善、卡钳宽度。Propensity score model, matching method (nearest neighbor/kernel), post-matching SMD improvement, caliper width.

必需项Required
要素 04Element 04

平均处理效应(ATT)Average Treatment Effect (ATT)

干预组相对于配对对照组的平均因果效应量,附95%置信区间和p值。Average causal effect of the treatment group relative to matched controls, with 95% CI and p-value.

必需项Required
要素 05Element 05

健康结果指标Health Outcome Metrics

主要结局(如心血管风险评分)与次要结局(如血压、血脂、住院率)的变化量。Primary outcome (e.g., cardiovascular risk score) and secondary outcomes (blood pressure, lipids, hospitalization rate) changes.

必需项Required
要素 06Element 06

适用范围与局限性Scope and Limitations

证据适用的人群特征、随访时长限制、未测量混杂因素声明、AI生成内容免责说明。Applicable population characteristics, follow-up duration limits, unmeasured confounders declaration, AI-generated content disclaimer.

必需项Required

可结算证据的三个等级Three Levels of Billable Evidence

Level 1

群体趋势证据Group Trend Evidence

基于干预前后统计对比,未完全消除混杂因素。适用于企业健康管理年度汇报、内部绩效评估,不建议直接用于保险结算。Pre/post statistical comparison without fully eliminating confounders. Suitable for annual reports and internal performance, not recommended for insurance settlement.

Level 2

PSM因果归因证据PSM Causal Attribution Evidence

通过倾向评分匹配消除可观测混杂因素,输出ATT及置信区间。适用于商业保险费率谈判、企业向保险方申请保费优惠、医院向医保部门的预防项目申报。PSM eliminates observable confounders, outputs ATT and CI. Suitable for commercial insurance rate negotiations, employer premium discount applications, hospital prevention program submissions.

Level 3

多中心联邦RWE证据Multi-Center Federated RWE Evidence

跨多家机构、基于联邦学习的大样本PSM因果报告,符合NMPA RWE最高等级要求。适用于药企注册申报、医保战略合作谈判、行业标准制定参考。Multi-institution federated learning large-sample PSM reports meeting NMPA RWE highest standards. Suitable for pharma regulatory submissions and public insurance strategic negotiations.

可结算证据报告示例结构Sample Report Structure

PSM 因果归因证据报告 · ReHealth CoreCausal Attribution Evidence Report · ReHealth CoreLevel 2 · RWE
干预类型Intervention Type综合干预(生活方式 + 数字健康工具)Combined (Lifestyle + Digital Health)
随访时长Follow-up Duration12 个月months
干预组样本量Treatment Group NN = 248
匹配后对照组Matched Control NN = 248 (1:1 最近邻匹配Nearest Neighbor)
匹配后 SMD(均值)Post-match SMD (Mean)0.042 (<0.1, 匹配质量良好Good Quality)
主要结局:风险评分下降Primary Outcome: Risk Score ReductionATT = -0.087 (p < 0.001)
95% CI[-0.112, -0.062]
次要结局:收缩压变化Secondary: Systolic BP Change-4.3 mmHg (p = 0.007)

常见问题Frequently Asked Questions

可结算证据和普通医疗记录有什么区别?How is billable evidence different from ordinary medical records?
普通医疗记录是描述性的,记录发生了什么。可结算证据是分析性的,证明干预前后的健康变化在统计意义上可归因于干预本身,而非自然恢复或安慰剂效应。这需要因果推断方法(如PSM)而非简单的前后对比。Medical records are descriptive — they document what happened. Billable evidence is analytical — it proves that health changes are statistically attributable to the intervention itself, not natural recovery or placebo effects. This requires causal inference methods like PSM, not simple before/after comparisons.
哪些支付方目前接受可结算证据?Which payers currently accept billable evidence?
商业保险公司是目前接受度最高的支付方,因为他们有直接的商业动机降低赔付风险。部分领先的大型雇主已开始采用。公立医保体系目前处于政策探索阶段,部分地区的慢病管理按效付费试点是最接近可结算证据框架的实践。Commercial insurers have the highest acceptance rate, driven by direct commercial incentives to reduce claims. Some leading large employers have begun adopting it. Public health insurance is in the policy exploration phase, with some regional chronic disease management pay-for-performance pilots being the closest existing practice.
一份可结算证据报告需要多大的样本量?What sample size is needed for a billable evidence report?
建议干预组至少100人,对照组候选池至少为干预组的3-5倍(以保证匹配成功率)。样本量越大,效应量估计越精确,置信区间越窄,对支付方的说服力越强。ReHealth Core的联邦学习框架可以跨机构扩大样本量,同时保持数据合规。At least 100 in the treatment group is recommended, with a control pool 3-5x larger. Larger samples produce more precise effect estimates with narrower confidence intervals. ReHealth Core's federated learning framework can expand sample sizes across institutions while maintaining compliance.

相关概念Related Concepts